002589
vs
S
Shanghai Composite
002589
Over the past 12 months, Realcan Pharmaceutical Group Co Ltd has underperformed Shanghai Composite, delivering a return of +24% compared to the Shanghai Composite's +27% growth.
Stocks Performance
002589 vs Shanghai Composite
Performance Gap
002589 vs Shanghai Composite
Performance By Year
002589 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Realcan Pharmaceutical Group Co Ltd
Glance View
Realcan Pharmaceutical Group Co., Ltd.. engages in the provision of medical services. The company is headquartered in Yantai, Shandong and currently employs 8,369 full-time employees. The company went IPO on 2011-06-10. The firm operates its businesses through three segments. The Medical segment is engaged in the provision of Chinese medicine materials, Chinese medicine tablets, Chinese patent medicines, chemical drug materials, chemical preparations, antibiotics, biochemical pharmaceuticals, biological products, psychotropic substances, anesthetic medicines and peptide hormones. The Equipment is engaged in the provision of medical equipment. The Mobile Medical segment is engaged in the provision of medical and logistics services and mobile medical information services. The firm conducts its businesses mainly within domestic markets, with Shandong as its main market.
